Dasatinib-Quercetin Senolytic Therapy Shows Subtle Bone Marker Changes but No Overall Bone Density Improvements in Postmenopausal Women
A placebo-controlled trial testing dasatinib plus quercetin in postmenopausal women with low bone density revealed marg…